ENDEFR
Home › United States › DRAXIS PHARMA L.L.C.

DRAXIS PHARMA L.L.C.

Limited Liability Company · Wilmington, United States · LEI 254900GN2NTM7K5X9L64
LEI active

Summary

DRAXIS PHARMA L.L.C. is registered in the United States. Its legal form is Limited Liability Company. According to GLEIF, its ultimate parent is JUBILANT PHARMOVA LIMITED (India), which is also its direct parent. That group has 14 subsidiaries with LEIs in 4 countries, 6 of them in the United States. The LEI was first issued on 29 Sep 2022 and the record was last updated on 8 Sep 2026; the next renewal is due by 29 Sep 2027. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Mar 2023, more than 24 months before this data release. The group may have changed since.

Company details

Legal formLimited Liability Company
Register · Register website
Registration number4733702
Registration authorityDivision of Corporations, Department of State
JurisdictionUnited States (US-DE)
Registered addressC/O Corporation Service Company, 251 Little Falls Drive, 19808 Wilmington, United States
Headquarters address3525 N Regal Street, 99207 Spokane, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)21 Sep 2009
LEI254900GN2NTM7K5X9L64
LEI statusactive
LEI first issued29 Sep 2022
LEI record last updated8 Sep 2026
Next LEI renewal29 Sep 2027
Corroboration of the LEI recordfully corroborated

Group membership

JUBILANT PHARMOVA LIMITED India ultimate parent
DRAXIS PHARMA L.L.C. this entity
View the whole group: 14 subsidiaries in 4 countries

Relationship to the parent

Direct parentUltimate parent
ParentJUBILANT PHARMOVA LIMITEDJUBILANT PHARMOVA LIMITED
Accounting period1 Apr 2022 to 31 Mar 20231 Apr 2022 to 31 Mar 2023
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Consolidation percentage reported to GLEIF100.00%100.00%
Relationship start21 Sep 200921 Sep 2009
Recorded at GLEIF since29 Sep 202229 Sep 2022
Last updated23 Sep 202523 Sep 2025
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (10)